PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study

Summary

This prospective cohort study aims to determine whether high-risk coronary plaques identified by novel Photon-Counting Detector CT (PCCT) independently predict future major adverse cardiovascular events (MACE). Participants will be followed for MACE and revascularization. The primary hypothesis is that the incidence of MACE is significantly higher in patients with PCCT-defined high-risk plaque than in those without. Additionally, patients will undergo Optical Coherence Tomography (OCT) and angiography within a month after PCCT; PCCT results will be compared with OCT in a cross-sectional analysis, and diagnostic performance will be evaluated against follow-up data.

Eligibility

Inclusion Criteria:

* Age ≥18 years
* Scheduled for clinically indicated, non-emergent invasive coronary angiography
* Provision of written informed consent and willingness to comply with long-term follow-up

Exclusion Criteria:

* Estimated glomerular filtration rate \<45 mL/min/1.73 m²
* Known allergy to iodinated contrast media
* Pregnancy or breastfeeding
* Persistent atrial fibrillation or other arrhythmia precluding adequate ECG-gated CT acquisition
* Body mass index \>40 kg/m²
* Target vessel with a previously implanted stent
* Life expectancy \<2 years or any condition that, in the opinion of the investigator, makes follow-up unlikely or participation inappropriate

Conditions4

Browse More Trials